Events

Press Center


07.08.2014
The Vladimir Potanin Foundation announced the results of the grant competition, which started in January 2014 in the framework of the Olympic Scholarships Program. The purpose of the program is to help future sports managers to get a quality professional education in the Russian International Olympic University (RIOU) in Sochi.
More
Topics Charity / RIOU 
28.07.2014
According to Orange Book, a regular report by Synergy Research Group, Petrovax Pharm has become one of the Top 5 companies by number of clinical trials started in Q2 2014 in the Russian pharmaceuticals market.
More
Topics Petrovax Pharm 
12.05.2014
The immunobiological production unit of NPO Petrovax Pharm, a Russian pharmaceutical company, has produced more than 2.5 mln doses of Prevenar 13, a 13-valent conjugate pneumococcal vaccine, in easy to use disposable auto injectors. More than 5 mln doses are planned to be produced by the end of 2014.
More
Topics Petrovax Pharm 
26.03.2014
On March 26, 2014, NPO Petrovax Pharm ran a media tour for key business and industry journalists at the Company's production site in the Podolsk District of Moscow Region. The journalists were taken on a tour around the unique facility where 13-valent conjugate pneumococcal vaccine is produced.
More
Topics Petrovax Pharm